Glynium Respules (2ml Each)

This medication is particularly beneficial for patients who require maintenance therapy to control symptoms of bronchoconstriction and reduce exacerbations. The 2 ml respules are designed for use with standard nebulizer devices, ensuring efficient delivery of the drug to the lower respiratory tract. Glycopyrrolate exhibits a prolonged duration of action, allowing for twice-daily dosing in most cases.

It is generally well tolerated; however, patients should be monitored for potential anticholinergic side effects such as dry mouth, urinary retention, and tachycardia. Glynium Respules should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. It is contraindicated in patients with hypersensitivity to glycopyrrolate or other anticholinergic agents.